0002109829-26-000001.txt : 20260205 0002109829-26-000001.hdr.sgml : 20260205 20260205145536 ACCESSION NUMBER: 0002109829-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260205 DATE AS OF CHANGE: 20260205 EFFECTIVENESS DATE: 20260205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Immunomet Therapeutics, Inc. CENTRAL INDEX KEY: 0002109829 ORGANIZATION NAME: EIN: 474629617 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-572548 FILM NUMBER: 26602474 BUSINESS ADDRESS: STREET 1: 2450 HOLCOMBE BLVD. CITY: HOUSTON STATE: TX ZIP: 77021 BUSINESS PHONE: 346-772-0318 MAIL ADDRESS: STREET 1: 2450 HOLCOMBE BLVD. CITY: HOUSTON STATE: TX ZIP: 77021 D 1 primary_doc.xml X0708 D LIVE 0002109829 Immunomet Therapeutics, Inc. 2450 HOLCOMBE BLVD. HOUSTON TX TEXAS 77021 346-772-0318 DELAWARE None None Corporation true Dean Welsch 2450 Holcombe Blvd. Houston TX TEXAS 77021 Executive Officer Director Biotechnology Decline to Disclose 06b false 2026-01-21 false true true false 0 10000000 842211 9157789 false 4 0 0 220000 true false Immunomet Therapeutics, Inc. Dean Welsch Dean Welsch Chief Executive Officer 2026-02-05